Immediate Impact
1 from Science/Nature 50 standout
Citing Papers
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
2025 Standout
CAR T therapies in multiple myeloma: unleashing the future
2024 Standout
Works of Barbara Ferstl being referenced
MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial
2020
Phase I/IIa Study of the Human Anti-CD38 Antibody MOR202 (MOR03087) in Relapsed or Refractory Multiple Myeloma
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Barbara Ferstl | 149 | 112 | 55 | 103 | 13 | 312 | |
| Mark Mendonça | 139 | 196 | 12 | 115 | 11 | 329 | |
| Thomas Rückrich | 116 | 86 | 20 | 257 | 8 | 356 | |
| Makoto Takishita | 100 | 73 | 97 | 116 | 11 | 339 | |
| Ilseyar Akhmetzyanova | 84 | 148 | 16 | 87 | 10 | 363 | |
| Fred Goldman | 138 | 36 | 59 | 78 | 15 | 370 | |
| T Sylwestrowicz | 85 | 40 | 53 | 171 | 16 | 366 | |
| DH Ryan | 149 | 59 | 40 | 86 | 13 | 353 | |
| Mustapha Cheraï | 112 | 86 | 30 | 98 | 14 | 362 | |
| Rene Costello | 191 | 79 | 59 | 132 | 18 | 284 | |
| Susan M. Tollerfield | 129 | 108 | 158 | 73 | 9 | 355 |
All Works
Loading papers...